Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy
スポンサーリンク
概要
- 論文の詳細を見る
It has been reported that sigma receptors are highly expressed in a variety of human tumors. In this study, we selected (+)-2-[4-(4-iodophenyl)piperidino] cyclohexanol [(+)-pIV] as a sigma receptor ligand and evaluated the potential of radioiodinated (+)-pIV for tumor imaging and therapy. (+)-[125/131I]pIV was prepared by an iododestannylation reaction under no-carrier-added conditions with radiochemical purity over 99% after HPLC purification. Biodistribution experiments were performed by the intravenous injection of (+)-[125I]pIV into mice bearing human prostate tumors (DU-145). Blocking studies were performed by intravenous injection of (+)-[125I]pIV mixed with an excess amount of unlabeled sigma ligand into DU-145 tumor-bearing mice. For therapeutic study, (+)-[131I]pIV was injected at a dose of 7.4 MBq followed by measurement of the tumor size. In biodistribution experiments, (+)-[125I]pIV showed high uptake and long residence in the tumor. High tumor to blood and muscle ratios were achieved because the radioactivity levels of blood and muscle were low. However, the accumulations of radioactivity in non-target tissues, such as liver and kidney, were high. The radioactivity in the non-target tissues slowly decreased over time. Co-injection of (+)-[125I]pIV with an excess amount of unlabeled sigma ligand resulted in a significant decrease in the tumor/blood ratio, indicating sigma receptor-mediated tumor uptake. In therapeutic study, tumor growth in mice treated with (+)-[131I]pIV was significantly inhibited compared to that of an untreated group. These results indicate that radioiodinated (+)-pIV has a high potential for sigma receptor imaging in tumor and radionuclide receptor therapy. (Cancer Sci 2009). © 2009 Japanese Cancer Association.
著者
-
絹谷 清剛
Department Of Nuclear Medicine Kanazawa University Hospital
-
Shiba Kazuhiro
Kanazawa Univ. Kanazawa Jpn
関連論文
- ^Tc-sestamibi to monitor treatment with antisense oligodeoxynucleotide complementary to MRP mRNA in human breast cancer cells
- 大容量I-131 MIBGによる悪性褐色細胞腫治療の試み
- 悪性褐色細胞腫に対する^I-MIBG内照射療法
- 循環器SPECTの最新トピックス (特集 核医学の最前線)
- Characterization of cartilaginous tumors with ^Tl scintigraphy
- Failure of radioiodine treatment in Graves' disease intentionally caused by a patient : Suspected Munchausen syndrome
- Brown adipose tissue : Evaluation with ^Tl and ^Tc-sestamibi dual-tracer SPECT
- Left ventricular ejection and filling rate measurement based on the automatic edge detection method of ECG-gated blood pool single-photon emission tomography
- Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma
- Preliminary evaluation of image reconstruction by ordered-subset expectation maximization in thallium-201 lung scintigraphy
- Discrepant uptake between fluorine-18 fluorodeoxy glucose and Tc-99m sestamibi in bronchioloalveolar cell carcinoma
- SF-063-2 RI法で同定されたセンチネルリンパ節における,RIコロイドのリンパ節内局在の描出
- オートラジオグラフィーを用いて画像化したRIコロイドの節内分布からみた, 胃癌RI法センチネルリンパ節生検における, フチン酸とスズコロイドの比較(第105回日本外科学会定期学術集会)
- Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer
- ^I-MIBG治療
- Single dose planning for radioiodine-131 therapy of Graves' disease
- Evaluation of radioiodinated vesamicol analogs for sigma receptor imaging in tumor and radionuclide receptor therapy
- 診療 冠動脈バイパス術後および虚血性心疾患疑い患者に対する心筋血流SPECTとCT冠動脈造影の融合画像診断の有用性
- 甲状腺癌の放射性ヨード内用療法におけるRI治療病室稼働状況の実態調査報告
- Clinical usefulness of novel cardiac MDCT/SPECT fusion image
- Synthesis and evaluation of vesamicol analog (-)-o-[^C]methylvesamicol as a PET ligand for vesicular acetylcholine transporter